Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China’s ZDG Options Canadian Medical Devices in a Potential Blockbuster Deal

publication date: Nov 8, 2013
Zhongguancun Development Group (ZDG), a state-owned science and technology investment company, signed an unusual 45-day exclusive option for seven medical devices that are being developed by Canada’s Medical Devices Innovation Institute (MDI). The option will allow ZDG to receive only preliminary information on each device. To get more details, ZDG will have to pay an additional $7 million. To see working prototypes, ZDG must invest somewhere between $500 million and $700 million. ZDG is affiliated with Beijing's Zhongguancun Science Park. More details...

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here